tiprankstipranks
Zhongzhi Pharmaceutical Holdings Limited (HK:3737)
:3737
Hong Kong Market
3737
Zhongzhi Pharmaceutical Holdings Limited
RESEARCH TOOLSreports
Want to see HK:3737 full AI Analyst Report?

Zhongzhi Pharmaceutical Holdings Limited (3737) Ratios

0 Followers

Zhongzhi Pharmaceutical Holdings Limited Ratios

HK:3737's free cash flow for Q4 2025 was ¥0.53. For the 2025 fiscal year, HK:3737's free cash flow was decreased by ¥ and operating cash flow was ¥<0.01. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.60 1.60 1.39 1.44 1.49
Quick Ratio
 1.15 1.15 0.91 0.89 1.05
Cash Ratio
 0.32 0.32 0.23 0.27 0.52
Solvency Ratio
 0.10 0.10 0.17 0.36 0.18
Operating Cash Flow Ratio
 0.13 0.17 0.25 0.17 0.39
Short-Term Operating Cash Flow Coverage
 0.58 0.74 3.92 1.31 7.90
Net Current Asset Value
¥ 263.77M¥ 263.77M¥ 148.54M¥ 134.82M¥ 221.61M
Leverage Ratios
Debt-to-Assets Ratio
 0.12 0.12 0.09 0.13 0.09
Debt-to-Equity Ratio
 0.21 0.21 0.17 0.21 0.17
Debt-to-Capital Ratio
 0.17 0.17 0.14 0.18 0.15
Long-Term Debt-to-Capital Ratio
 0.03 0.03 0.03 0.02 0.00
Financial Leverage Ratio
 1.67 1.67 1.78 1.71 1.87
Debt Service Coverage Ratio
 0.26 0.37 2.24 3.21 3.06
Interest Coverage Ratio
 1.57 0.94 18.57 21.58 16.24
Debt to Market Cap
 0.31 0.41 0.11 0.09 0.04
Interest Debt Per Share
 0.27 0.27 0.23 0.27 0.21
Net Debt to EBITDA
 0.47 0.47 0.13 0.19 -1.37
Profitability Margins
Gross Profit Margin
54.12%54.12%58.17%59.43%58.45%
EBIT Margin
-0.10%-0.10%5.39%10.51%5.67%
EBITDA Margin
3.18%3.18%7.69%15.49%8.43%
Operating Profit Margin
0.28%0.28%5.86%8.28%5.83%
Pretax Profit Margin
1.09%1.09%6.63%10.13%7.16%
Net Profit Margin
1.00%1.00%4.30%7.94%5.83%
Continuous Operations Profit Margin
0.07%1.02%4.34%8.01%5.86%
Net Income Per EBT
91.06%91.06%64.82%78.42%81.43%
EBT Per EBIT
385.21%385.21%113.13%122.24%122.76%
Return on Assets (ROA)
0.94%0.94%4.79%9.08%5.67%
Return on Equity (ROE)
1.59%1.58%8.53%15.52%10.61%
Return on Capital Employed (ROCE)
0.41%0.41%10.34%14.34%9.30%
Return on Invested Capital (ROIC)
0.02%0.34%6.35%10.25%8.34%
Return on Tangible Assets
0.95%0.95%4.82%9.16%5.73%
Earnings Yield
3.00%3.98%12.11%14.77%13.05%
Efficiency Ratios
Receivables Turnover
 3.93 3.93 5.04 6.25 5.86
Payables Turnover
 4.84 4.84 4.39 4.87 4.20
Inventory Turnover
 2.84 2.84 2.68 2.52 2.35
Fixed Asset Turnover
 2.58 2.58 3.03 3.09 3.18
Asset Turnover
 0.95 0.95 1.11 1.14 0.97
Working Capital Turnover Ratio
 4.87 5.29 8.08 6.56 5.10
Cash Conversion Cycle
 145.93 145.93 125.37 128.31 130.80
Days of Sales Outstanding
 92.84 92.84 72.44 58.40 62.28
Days of Inventory Outstanding
 128.52 128.52 136.07 144.84 155.37
Days of Payables Outstanding
 75.43 75.43 83.15 74.93 86.85
Operating Cycle
 221.36 221.36 208.51 203.24 217.65
Cash Flow Ratios
Operating Cash Flow Per Share
 0.10 0.12 0.21 0.12 0.34
Free Cash Flow Per Share
 0.05 0.08 0.05 -0.08 0.23
CapEx Per Share
 0.04 0.04 0.17 0.20 0.10
Free Cash Flow to Operating Cash Flow
 0.57 0.67 0.22 -0.69 0.69
Dividend Paid and CapEx Coverage Ratio
 1.09 1.45 1.10 0.35 3.21
Capital Expenditure Coverage Ratio
 2.31 3.04 1.28 0.59 3.22
Operating Cash Flow Coverage Ratio
 0.36 0.46 0.96 0.45 1.67
Operating Cash Flow to Sales Ratio
 0.05 0.06 0.08 0.05 0.16
Free Cash Flow Yield
8.08%16.07%5.04%-6.34%24.06%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 33.31 25.15 8.26 6.77 7.66
Price-to-Sales (P/S) Ratio
 0.33 0.25 0.35 0.54 0.45
Price-to-Book (P/B) Ratio
 0.53 0.40 0.70 1.05 0.81
Price-to-Free Cash Flow (P/FCF) Ratio
 12.38 6.22 19.84 -15.76 4.16
Price-to-Operating Cash Flow Ratio
 7.07 4.17 4.33 10.86 2.86
Price-to-Earnings Growth (PEG) Ratio
 -0.41 -0.31 -0.20 0.15 0.07
Price-to-Fair Value
 0.53 0.40 0.70 1.05 0.81
Enterprise Value Multiple
 10.80 8.34 4.74 3.66 3.93
Enterprise Value
 597.31M 460.99M 807.59M 1.16B 605.06M
EV to EBITDA
 10.80 8.34 4.74 3.66 3.93
EV to Sales
 0.34 0.27 0.36 0.57 0.33
EV to Free Cash Flow
 12.94 6.60 20.38 -16.63 3.08
EV to Operating Cash Flow
 7.33 4.42 4.45 11.46 2.13
Tangible Book Value Per Share
 1.28 1.26 1.31 1.21 1.17
Shareholders’ Equity Per Share
 1.29 1.27 1.32 1.22 1.18
Tax and Other Ratios
Effective Tax Rate
 0.93 0.07 0.35 0.21 0.18
Revenue Per Share
 2.04 2.01 2.62 2.39 2.16
Net Income Per Share
 0.02 0.02 0.11 0.19 0.13
Tax Burden
 0.91 0.91 0.65 0.78 0.81
Interest Burden
 -11.35 -11.35 1.23 0.96 1.26
Research & Development to Revenue
 0.02 0.02 0.03 0.02 0.03
SG&A to Revenue
 0.51 0.51 0.49 0.05 0.06
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 4.75 6.19 1.24 0.49 2.67
Currency in CNY